The emerging complexity of gene fusions in cancer

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Nature Reviews. Cancer

• Publication date

  2015-05-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nrc3947PMID 25998716
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Emergence of FGFR family gene fusions as therapeutic targets in a wide spectrum of solid tumours

  2014cited by this paper
• Microfluidic, marker-free isolation of circulating tumor cells from blood samples

  2014cited by this paper
• High-Throughput Detection of Clinically Relevant Mutations in Archived Tumor Samples by Multiplexed PCR and Next-Generation Sequencing

  2014cited by this paper
• Chimeric RNAs generated by intergenic splicing in normal and cancer cells

  2014cited by this paper
• Fusions involving protein kinase C and membrane-associated proteins in benign fibrous histiocytoma.

  2014cited by this paper
• Comprehensive molecular characterization of gastric adenocarcinoma

  2014cited by this paper
• Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics

  2014cited by this paper
• STAT6 is amplified in a subset of dedifferentiated liposarcoma

  2014cited by this paper
• Mitelman database of chromosome aberrations and gene fusions in cancer

  2014cited by this paper
• Mitelman Database (Chromosome Aberrations and Gene Fusions in Cancer)

  2014cited by this paper
• Pharmacogenomic Modeling of Circulating Tumor and Invasive Cells for Prediction of Chemotherapy Response and Resistance in Pancreatic Cancer

  2014cited by this paper
• Molecular Pathways Molecular Pathways : Targeting ETS Gene Fusions in Cancer

  2014cited by this paper
• The landscape and therapeutic relevance of cancer-associated transcript fusions

  2014cited by this paper
• Comprehensive molecular profiling of lung adenocarcinoma

  2014cited by this paper
• Recurrent PRDM10 Gene Fusions in Undifferentiated Pleomorphic Sarcoma

  2014cited by this paper
• Targeting BCL2 for the treatment of lymphoid malignancies.

  2014cited by this paper
• Next-Generation Sequencing of RNA and DNA Isolated from Paired Fresh-Frozen and Formalin-Fixed Paraffin-Embedded Samples of Human Cancer and Normal Tissue

  2014cited by this paper
• A novel flow cytometry-based cell capture platform for the detection, capture and molecular characterization of rare tumor cells in blood

  2014cited by this paper
• Comprehensive molecular characterization of urothelial bladder carcinoma

  2014cited by this paper
• The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes

  2014cited by this paper
• Breaking bad in the germinal center: how deregulation of BCL6 contributes to lymphomagenesis.

  2014cited by this paper
• State-of-the-Art Fusion-Finder Algorithms Sensitivity and Specificity

  2013cited by this paper
• High-throughput DNA sequencing errors are reduced by orders of magnitude using circle sequencing

  2013cited by this paper
• The MLL recombinome of acute leukemias in 2013

  2013cited by this paper
• Cancer Genome Landscapes

  2013influential reference
• Clinical Applications of Novel ERG Immunohistochemistry in Prostate Cancer Diagnosis and Management

  2013cited by this paper
• Sequencing error correction without a reference genome

  2013cited by this paper
• Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.

  2013cited by this paper
• COMPREHENSIVE MOLECULAR CHARACTERIZATION OF CLEAR CELL RENAL CELL CARCINOMA

  2013cited by this paper
• The integrated landscape of driver genomic alterations in glioblastoma

  2013cited by this paper
• Whole exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors

  2013cited by this paper
• Signatures of mutational processes in human cancer

  2013influential reference
• Integrated genomic characterization of endometrial carcinoma

  2013cited by this paper
• Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing

  2013cited by this paper
• Liquid biopsy: monitoring cancer-genetics in the blood

  2013cited by this paper
• Tyrosine kinase gene rearrangements in epithelial malignancies

  2013cited by this paper
• WHO classification of tumours of soft tissue and bone

  2013cited by this paper
• Comprehensive genetic analysis identifies a pathognomonic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumor

  2013cited by this paper
• RET fusion gene: Translation to personalized lung cancer therapy

  2013cited by this paper
• Histone lysine demethylases as targets for anticancer therapy

  2013cited by this paper
• Emerging patterns of somatic mutations in cancer

  2013cited by this paper
• ALK status testing in non-small cell lung carcinoma: correlation between ultrasensitive IHC and FISH.

  2013cited by this paper
• Comprehensive molecular characterization of human colon and rectal cancer

  2012cited by this paper
• Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.

  2012cited by this paper
• Digital RNA sequencing minimizes sequence-dependent bias and amplification noise with optimized single-molecule barcodes

  2012cited by this paper
• The molecular basis of T cell acute lymphoblastic leukemia.

  2012cited by this paper
• Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma

  2012cited by this paper
• Adjuvant treatment of GIST: patient selection and treatment strategies

  2012cited by this paper
• Identification of a novel, recurrent HEY1‐NCOA2 fusion in mesenchymal chondrosarcoma based on a genome‐wide screen of exon‐level expression data

  2012cited by this paper
• Flipping the cyclin D1 switch in mantle cell lymphoma.

  2012cited by this paper
• Recurrent R-spondin fusions in colon cancer

  2012cited by this paper
• Comprehensive genomic characterization of squamous cell lung cancers

  2012cited by this paper
• Recent advances on NOTCH signaling in T-ALL.

  2012cited by this paper
• Gene fusions associated with recurrent amplicons represent a class of passenger aberrations in breast cancer.

  2012cited by this paper
• FUS-CREB3L2/L1–Positive Sarcomas Show a Specific Gene Expression Profile with Upregulation of CD24 and FOXL1

  2011cited by this paper
• Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion

  2011cited by this paper
• Use of whole-genome sequencing to diagnose a cryptic fusion oncogene.

  2011cited by this paper
• MUC4 Is a Highly Sensitive and Specific Marker for Low-grade Fibromyxoid Sarcoma

  2011cited by this paper
• MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers

  2011cited by this paper
• Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA

  2011cited by this paper
• Autopsy

  2011cited by this paper
• Towards individualized follow-up in adult acute myeloid leukemia in remission.

  2011cited by this paper
• PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies

  2011cited by this paper
• Trans-splicing in Higher Eukaryotes: Implications for Cancer Development?

  2011cited by this paper
• TopHat-Fusion: an algorithm for discovery of novel fusion transcripts

  2011cited by this paper
• Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samples

  2011cited by this paper
• Philadelphia chromosome‐positive acute lymphoblastic leukemia

  2011cited by this paper
• RNA sequencing: advances, challenges and opportunities

  2011cited by this paper
• Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing

  2010cited by this paper
• Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.

  2010cited by this paper
• Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials.

  2010cited by this paper
• Deregulation of the telomerase reverse transcriptase (TERT) gene by chromosomal translocations in B-cell malignancies.

  2010cited by this paper
• Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogenetique Hematologique study.

  2010cited by this paper
• Absence of the JAZF1/SUZ12 chimeric transcript in the immortalized non-neoplastic endometrial stromal cell line T HESCs.

  2010cited by this paper
• Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia.

  2009cited by this paper
• Rearrangement of CRLF2 in B-progenitor– and Down syndrome–associated acute lymphoblastic leukemia

  2009cited by this paper
• Transcriptome Sequencing to Detect Gene Fusions in Cancer

  2009cited by this paper
• Alveolar rhabdomyosarcoma: a cytogenetic and correlated cytological and histological study.

  2009cited by this paper
• The t(X;7)(q22;q34) in paediatric T‐cell acute lymphoblastic leukaemia results in overexpression of the insulin receptor substrate 4 gene through illegitimate recombination with the T‐cell receptor beta locus

  2009cited by this paper
• Chimeric transcript discovery by paired-end transcriptome sequencing

  2009cited by this paper
• SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer.

  2009cited by this paper
• Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.

  2009cited by this paper
• COMPLEX LANDSCAPES OF SOMATIC REARRANGEMENT IN HUMAN BREAST CANCER GENOMES

  2009cited by this paper
• Implications of chimaeric non-co-linear transcripts

  2009cited by this paper
• Translation of the Philadelphia chromosome into therapy for CML.

  2008cited by this paper
• Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes

  2008cited by this paper
• Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing

  2008cited by this paper
• The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children.

  2007cited by this paper
• Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer

  2007cited by this paper
• Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.

  2007cited by this paper
• Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

  2007cited by this paper
• MLL translocations, histone modifications and leukaemia stem-cell development

  2007cited by this paper
• Paired-End Mapping Reveals Extensive Structural Variation in the Human Genome

  2007cited by this paper
• Fusion gene‐mediated truncation of RUNX1 as a potential mechanism underlying disease progression in the 8p11 myeloproliferative syndrome

  2007cited by this paper
• Mechanisms of transcription factor deregulation in lymphoid cell transformation

  2007cited by this paper
• The impact of translocations and gene fusions on cancer causation

  2007influential reference
• The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia.

  2007cited by this paper
• WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues

  2007cited by this paper
• A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells.

  2006cited by this paper
• Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

  2006cited by this paper

• A de novo assembly based fusion gene detection concept based on DNA-seq data of 100 Ewing sarcoma cases

  2026cites this paper
• Systematic fusion transcript discovery in mantle cell lymphoma using long-read sequencing

  2026cites this paper
• An EV-Guided Multi-Compartment Proof-of-Concept Framework for Biomarker Prioritization in Cholangiocarcinoma

  2026cites this paper
• Targeted RNA Sequencing Enhances the Integrated Diagnosis of Bone and Soft Tissue Tumors.

  2026cites this paper
• GFSeeker: a splicing-graph-based approach for accurate gene fusion detection from long-read RNA sequencing data

  2026cites this paper
• EcDNA-borne structural variants drive oncogenic fusion transcript amplification.

  2026cites this paper
• The GF-NEO discovery platform unveils a [KQE][DG] sequence motif within fusion neoantigens in pediatric cancer

  2025cites this paper
• Fusions4U: a resource of validated and annotated gene fusions in 328 cancer cell lines

  2025cites this paper
• NAB2-STAT6 drives an EGR1-dependent neuroendocrine program in solitary fibrous tumors

  2025cites this paper
• Combining panel-based and whole-transcriptome-based gene fusion detection by long-read sequencing

  2025cites this paper
• Long and Accurate: How HiFi Sequencing is Transforming Genomics

  2025cites this paper
• Biopharmaceuticals—Current Information and New Challenges

  2025cites this paper
• “Putting the cart before the horse”: an update on promiscuous gene fusions in soft tissue tumors

  2025cites this paper
• Identification of the clinical and genetic characteristics of gliomas with gene fusions by integrated genomic and transcriptomic analysis

  2025cites this paper
• Detection of chimeric alpha-defensin transcripts and peptides in mouse Paneth cells

  2025cites this paper
• Distinct Signatures of Chromosomal Involvement in 59 251 Translocations Across 58 Tumor Types. A Novel Perspective

  2025cites this paper
• FGFR3-TACC3 fusion gene promotes glioblastoma malignant progression through the activation of STAT3 signaling pathway

  2025cites this paper
• Human papillomavirus integration induces oncogenic host gene fusions in oropharyngeal cancers.

  2025cites this paper
• Gene fusion detection in long-read transcriptome sequencing data with GFvoter

  2025cites this paper
• BCOR-rearranged sarcomas: In silico insights into altered domains and BCOR interactions

  2025cites this paper
• Understanding the Role of Rho GTPase Activating Protein and Bone Marrow Kinase X: A Novel Target in Gastric Cancer Treatment

  2025cites this paper
• FuSViz—visualization and interpretation of structural variation using cancer genomics and transcriptomics data

  2025cites this paper
• NRG1 fusion glycoproteins in cancer progression - Structural mechanisms and therapeutic potential: A review.

  2025cites this paper
• Leveraging mRNA technology for antigen based immuno-oncology therapies

  2025cites this paper
• Case Report: A rare RUNX1 rearrangement resulting from t(8;21)(p12;q22) in acute myeloid leukemia with plasmacytoid dendritic cell expansion

  2025cites this paper
• Clinical utility of targeted RNA sequencing in cancer molecular diagnostics

  2025influential citation
• Fusion transcripts landscape in hepatocellular carcinoma and potential impact on the expression of fusion partners

  2025cites this paper
• Gene Fusions as Potential Therapeutic Targets in Soft Tissue Sarcomas

  2025cites this paper
• Fusion genes in cancers: Biogenesis, functions, and therapeutic implications

  2025cites this paper
• Molecular features and clinical actionability of gene fusions in colorectal cancer.

  2025cites this paper
• Clinical Implementation of Expanded Solid Tumor Fusion Detection With Whole-Transcriptome Sequencing at an Academic Cancer Center

  2025cites this paper
• Electrochemical detection of fusion genes: Advancing cancer diagnosis and therapy

  2025cites this paper
• Detection of Cancer-Associated Gene Fusion by Ligation-Dependent RT-PCR.

  2025cites this paper
• ALK inhibitors against resistance in non-small cell lung cancer: an 18 year medical arms race.

  2025cites this paper
• Extracellular vesicles in cancer progression: mechanisms and significance.

  2025cites this paper
• EcDNA-borne PVT1 fusion stabilizes oncogenic mRNAs

  2025cites this paper
• Oncogenic gene fusions in cancer: from biology to therapy

  2025cites this paper
• Assessment of molecular and morphological dynamics during long-time in vitro cultivation of cryopreserved human ovarian tissue: risk of genetic alterations

  2025cites this paper
• Identification of malignant cells in single-cell transcriptomics data

  2025cites this paper
• Genetic and oncogenic features of RASGRF fusions

  2025cites this paper
• Detection of oncogenic fusions in colorectal cancer using a partner-agnostic next-generation sequencing approach

  2025cites this paper
• Next-generation sequencing in cancer diagnosis and treatment: clinical applications and future directions

  2025cites this paper
• FGFR as a Predictive Marker for Targeted Therapy in Gastrointestinal Malignancies: A Systematic Review

  2025cites this paper
• Deciphering IGH rearrangement complexity and detection strategies in acute lymphoblastic leukaemia

  2025cites this paper
• The landscape of cell lineage tracing

  2025cites this paper
• Off-target effects in CRISPR-Cas genome editing for human therapeutics: Progress and challenges

  2025cites this paper
• Development of CAR-T Therapies and Personalized Vaccines for the Treatment of Cholangiocarcinoma: Current Progress, Mechanisms of Action, and Challenges.

  2024cites this paper
• Uncovering the domain language of protein functionality and cell phenotypes using DANSy

  2024cites this paper
• Identification of BRCA new prognostic targets and neoantigen candidates from fusion genes

  2024cites this paper
• Hotspots and future trends of dermatofibrosarcoma protuberans

  2024cites this paper
• Pharmacological and Biological Targeting of FGFR1 in Cancer

  2024cites this paper
• The YAP1-MAML2 fusion drives tumorigenesis and sustains tumor growth

  2024cites this paper
• The Genetic and Molecular Drivers of Multiple Myeloma: Current Insights, Clinical Implications, and the Path Forward

  2024cites this paper
• Descriptive Analysis of Common Fusion Mutations in Papillary Thyroid Carcinoma in Hungary

  2024cites this paper
• Challenges and prospects in utilizing technologies for gene fusion analysis in cancer diagnostics

  2024cites this paper
• Transcriptomic profiles of myxofibrosarcoma and undifferentiated pleomorphic sarcoma correlate with clinical and genomic features

  2024cites this paper
• Effective requesting method to detect fusion transcripts in chronic myelomonocytic leukemia RNA-seq

  2024cites this paper
• Overexpression of Fibroblast Growth Factor 8 Is a Predictor of Impaired Survival in Esophageal Squamous Cell Carcinoma and Correlates with ALK/EML4 Alteration

  2024cites this paper
• ESR1 Fusions Invoke Breast Cancer Subtype-Dependent Enrichment of Ligand-Independent Oncogenic Signatures and Phenotypes

  2024cites this paper
• The landscape of fusion transcripts in plants: a new insight into genome complexity

  2024cites this paper
• Immunotherapies targeting the oncogenic fusion gene CLDN18-ARHGAP in gastric cancer

  2024cites this paper
• Breadth versus depth: whole transcriptome sequencing has reduced sensitivity for detection of clinically relevant fusions compared to RNA comprehensive genomic profiling

  2024cites this paper
• Conserved features and diversity attributes of chimeric RNAs across accessions in four plants

  2024cites this paper
• CTHRC1 modulates cell proliferation and invasion in hepatocellular carcinoma by DNA methylation

  2024cites this paper
• Aneuploidy in neoplasia: Single‐cell data on 83,862 tumors

  2024cites this paper
• Bioinformatic approaches for detection of fusion genes and trans-splicing products

  2024cites this paper
• PFusionDB: a comprehensive database of plant-specific fusion transcripts

  2024cites this paper
• YAP, TAZ, and Hippo-Dysregulating Fusion Proteins in Cancer

  2024cites this paper
• Transcriptional determinism and stochasticity contribute to the complexity of autism-associated SHANK family genes

  2024cites this paper
• Oncofusions – shaping cancer care

  2024cites this paper
• Tumor Antigens beyond the Human Exome

  2024cites this paper
• Bioinformatic Approaches for the Detection of Fusion Genes and trans-Splicing Products (A Review)

  2024cites this paper
• CRISPR-based rapid molecular diagnostic tests for fusion-driven leukemias.

  2024cites this paper
• Decoding the Versatile Landscape of Autophagic Protein VMP1 in Cancer: A Comprehensive Review across Tissue Types and Regulatory Mechanisms

  2024cites this paper
• Enhanced Detection of Novel Low-Frequency Gene Fusions via High-Yield Ligation and Multiplexed Enrichment Sequencing.

  2024cites this paper
• The neo-open reading frame peptides that comprise the tumor framome are a rich source of neoantigens for cancer immunotherapy.

  2024cites this paper
• Gene fusion and functional diversification of P450 genes facilitate thermophilic fungal adaptation to temperature change

  2024cites this paper
• The evolutionary impact of childhood cancer on the human gene pool

  2024cites this paper
• Cutaneous squamous cell carcinoma progression: what does a meta-analysis of transcriptomic studies tell us?

  2024cites this paper
• Unravelling a novel CTNND1-RAB6A fusion transcript: Implications in colon cancer cell migration.

  2024cites this paper
• [Fusion genes in salivary gland tumors].

  2024cites this paper
• Recent advances in the investigation of fusion RNAs and their role in molecular pathology of cancer.

  2024cites this paper
• Genetic and environmental associations of nonspecific chromosomal aberrations

  2024cites this paper
• p160 nuclear receptor coactivator family members and their role in rare fusion‑driven neoplasms (Review)

  2024cites this paper
• Transcriptional Determinism and Stochasticity Contribute to the Complexity of Autism Associated SHANK Family Genes

  2024cites this paper
• NUT-midline carcinoma of the lung with rare BRD3-NUTM1 fusion

  2024cites this paper
• Linking Gene Fusions to Bone Marrow Failure and Malignant Transformation in Dyskeratosis Congenita

  2024cites this paper
• NAB2-STAT6 drives an EGR1-dependent neuroendocrine program in Solitary Fibrous Tumors

  2024cites this paper
• Drug repositioning in thyroid cancer: from point mutations to gene fusions

  2024cites this paper
• Successive next-generation sequencing strategy for optimal fusion gene detection in non-small-cell lung cancer in clinical practice.

  2024cites this paper
• Widespread alteration of protein autoinhibition in human cancers.

  2024cites this paper
• Cancer fusion transcripts with human non-coding RNAs

  2024cites this paper
• Large-scale discovery of chromatin dysregulation induced by oncofusions and other protein-coding variants

  2024cites this paper
• RNA fusion in human retinal development

  2024cites this paper
• Phase separation-mediated biomolecular condensates and their relationship to tumor

  2024cites this paper
• MYCT1 inhibits hematopoiesis in diffuse large B-cell lymphoma by suppressing RUNX1 transcription

  2024influential citation
• A multi-faceted approach to unravel coding and non-coding gene fusions and target chimeric proteins in ataxia

  2024cites this paper
• Research progress on fusion genes in tumours

  2024cites this paper
• Germline gene fusions across species reveal the chromosomal instability regions and cancer susceptibility

  2023cites this paper
• 基于RNA-based NGS检测非小细胞肺癌融合基因临床实践中国专家共识

  2023cites this paper